Italia markets closed

AMGN Jan 2024 200.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
70,200,00 (0,00%)
Al 01:51PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente70,20
Aperto70,20
Denaro69,45
Lettera71,60
Prezzo d'esercizio200,00
Scadenza2024-01-19
Min-Max giorno70,20 - 70,20
Contratto - Min-MaxN/D
Volume3
Open Interest174
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery